Stay updated on Filgotinib and Lanraplenib in Female CLE Clinical Trial

Sign up to get notified when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib and Lanraplenib in Female CLE Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.2 to v3.8.0. The study record content is still unavailable on this page.
    Difference
    0.2%
    Check dated 2026-10-28T16:50:35.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about federal agencies transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-21T20:40:10.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-14T20:41:00.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T20:57:55.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of study content, signaling restricted access. A simple header and a Home link are shown.
    Difference
    18%
    Check dated 2026-09-23T21:39:36.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0 on the page, indicating an internal platform update. No study content or surrounding page information was modified.
    Difference
    0.0%
    Check dated 2026-09-16T22:26:23.000Z thumbnail image

Stay in the know with updates to Filgotinib and Lanraplenib in Female CLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.